| Bartt Aaron Nehrt, CRNA | |
|
1900 State St, Chester, IL 62233-1116 | |
| (618) 826-4581 | |
| (618) 826-3194 |
| Full Name | Bartt Aaron Nehrt |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 13 Years |
| Location | 1900 State St, Chester, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396017133 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 209009387 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Health St Anthony Hospital - Oklahoma City | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ssm Health Care Of Oklahoma, Inc. | 6709771207 | 35 |
News Archive
More than 300 million play soccer across the globe and while the game is one of fast footwork, two organizations are trying to make sure these athletes stay on their feet. F-d-ration Internationale de Football Association (FIFA) and International Cartilage Repair Society (ICRS) have teamed up on a special supplement of Cartilage (published by SAGE) that examines the effects of articular cartilage injury and degeneration in soccer players.
Changes to HER2 testing guidelines for breast cancer in 2013 significantly increased the number of patients who test HER2-positive, according to a new study by Mayo Clinic researchers published in the Journal of Clinical Oncology.
PEPFAR has "met or even surpassed most" of its "bold goals," including "saving the lives of millions of people; supporting the scale-up of HIV prevention, care, and treatment; and strengthening systems and policies for the HIV response," Robert Black of the Johns Hopkins Bloomberg School of Public Health writes in a Lancet opinion piece, noting the release of the Institute of Medicine's (IOM) "Evaluation of PEPFAR" on Wednesday.
Cepheid today announced the U.S. Food & Drug Administration (FDA) has categorized Cepheid's Xpert CT/NG test as 'Moderate Complexity' under the Clinical Laboratory Improvement Amendments (CLIA).
Eisai Inc., the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., and FORMA Therapeutics announced today that the two companies have signed a strategic drug discovery collaboration.
› Verified 2 days ago
| Entity Name | Ssm Health Care Of Oklahoma, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033283932 PECOS PAC ID: 6709771207 Enrollment ID: O20040216000184 |
News Archive
More than 300 million play soccer across the globe and while the game is one of fast footwork, two organizations are trying to make sure these athletes stay on their feet. F-d-ration Internationale de Football Association (FIFA) and International Cartilage Repair Society (ICRS) have teamed up on a special supplement of Cartilage (published by SAGE) that examines the effects of articular cartilage injury and degeneration in soccer players.
Changes to HER2 testing guidelines for breast cancer in 2013 significantly increased the number of patients who test HER2-positive, according to a new study by Mayo Clinic researchers published in the Journal of Clinical Oncology.
PEPFAR has "met or even surpassed most" of its "bold goals," including "saving the lives of millions of people; supporting the scale-up of HIV prevention, care, and treatment; and strengthening systems and policies for the HIV response," Robert Black of the Johns Hopkins Bloomberg School of Public Health writes in a Lancet opinion piece, noting the release of the Institute of Medicine's (IOM) "Evaluation of PEPFAR" on Wednesday.
Cepheid today announced the U.S. Food & Drug Administration (FDA) has categorized Cepheid's Xpert CT/NG test as 'Moderate Complexity' under the Clinical Laboratory Improvement Amendments (CLIA).
Eisai Inc., the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., and FORMA Therapeutics announced today that the two companies have signed a strategic drug discovery collaboration.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bartt Aaron Nehrt, CRNA 29 Knollwood Dr, Chester, IL 62233-1416 Ph: (303) 335-8302 | Bartt Aaron Nehrt, CRNA 1900 State St, Chester, IL 62233-1116 Ph: (618) 826-4581 |
News Archive
More than 300 million play soccer across the globe and while the game is one of fast footwork, two organizations are trying to make sure these athletes stay on their feet. F-d-ration Internationale de Football Association (FIFA) and International Cartilage Repair Society (ICRS) have teamed up on a special supplement of Cartilage (published by SAGE) that examines the effects of articular cartilage injury and degeneration in soccer players.
Changes to HER2 testing guidelines for breast cancer in 2013 significantly increased the number of patients who test HER2-positive, according to a new study by Mayo Clinic researchers published in the Journal of Clinical Oncology.
PEPFAR has "met or even surpassed most" of its "bold goals," including "saving the lives of millions of people; supporting the scale-up of HIV prevention, care, and treatment; and strengthening systems and policies for the HIV response," Robert Black of the Johns Hopkins Bloomberg School of Public Health writes in a Lancet opinion piece, noting the release of the Institute of Medicine's (IOM) "Evaluation of PEPFAR" on Wednesday.
Cepheid today announced the U.S. Food & Drug Administration (FDA) has categorized Cepheid's Xpert CT/NG test as 'Moderate Complexity' under the Clinical Laboratory Improvement Amendments (CLIA).
Eisai Inc., the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., and FORMA Therapeutics announced today that the two companies have signed a strategic drug discovery collaboration.
› Verified 2 days ago